Expert insights

What should patients know about the risk of GvHD after stem cell transplantation?

Know GvHD was pleased to speak with Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, What should patients know about the risk of graft-versus-host disease (GvHD) after stem cell transplantation?

How can healthcare teams help patients living with GvHD feel supported throughout their journey?

Know GvHD was pleased to speak to Michelle Kenyon, King’s College Hospital NHS Foundation Trust, London, UK. We asked, How can healthcare teams help patients living with GvHD feel supported throughout their journey?

What strategies do you use to manage skin and liver GvHD?

Know GvHD was pleased to speak to Matea Meden, HR. We asked, What strategies do you use to manage skin and liver GvHD?

How do you include a patient’s perspective when selecting treatment and monitoring response in GvHD?

Know GvHD was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, How do you incorporate the patient’s perspective when selecting treatments and monitoring responses in GvHD?

What does responding to treatment mean to you, and does this differ from a physician’s perspective?

Know GvHD was pleased to speak to Joanne Stobart, UK. We asked, What does responding to treatment mean to you, and have you ever felt that this differs from a physician’s perspective?

How can patients become involved in clinical trials, and why is it important to capture their experience?

Know GvHD was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, How can patients become involved in clinical trials, and why is it important to capture their experience?

How do physicians decide which treatment to use in patients with GvHD?

Know GvHD was pleased to speak to Hildegard Greinix, Medical University of Vienna, Austria. We asked, How do physicians decide which treatment to use in patients with graft-versus-host disease (GvHD)?

What is steroid-refractory GvHD, and how is it treated?

Know GvHD was pleased to speak to Hildegard Greinix, Medical University of Vienna, Austria. We asked, What is steroid-refractory graft-versus-host disease (GvHD), and how is it treated?

What can patients expect after a GvHD diagnosis, and how can they manage the impact?

Know GvHD was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, What can patients expect after a GvHD diagnosis, and how can they manage the impact?

What strategies did you use to help deal with the news of your GvHD diagnosis?

What strategies did you use to help deal with the news of your GvHD diagnosis?

How has GvHD impacted your lifestyle?

Know GvHD was pleased to speak to Wilfred Emmanuel-Jones, UK, about how GvHD impacted his lifestyle.

What was your experience of GvHD treatment, and what were the most challenging parts of it?

Know GvHD was pleased to speak to Joanne Stobart, UK. We asked, What was your experience of GvHD treatment, and what were the most challenging parts of it?

Can you describe your treatment journey as a patient with GvHD?

Know GvHD was pleased to speak to Wilfred Emmanuel-Jones, UK, about his treatment journey as a patient with GvHD.

What advice would you give to someone who is about to start treatment for GvHD?

Know GvHD was pleased to speak to Joanne Stobart, UK. We asked, What advice would you give to someone who is about to start treatment for GvHD?

Have you experienced other complications due to treatments you received for GvHD?

Know GvHD was pleased to speak to Steven Jackson, US. We asked, Have you experienced other complications due to treatments you received for GvHD?